C. Aschele, L. Cionini, S. Lonardi, C. Pinto, S. Cordio et al., Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally

C. Borg, T. André, G. Mantion, F. Boudghène, and F. Mornex, Maingon P et al Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study, Ann Oncol, vol.11, pp.2205-2215, 2014.

J. Gérard, D. Azria, S. Gourgou-bourgade, I. Martel-lafay, and C. Hennequin, Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer, Journal of Clinical Oncology, vol.30, issue.36, pp.4558-65, 2012.
DOI : 10.1200/JCO.2012.42.8771

A. Habr-gama, P. Lynn, J. Jorge, S. Julião, G. Proscurshim et al., Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation, Diseases of the Colon & Rectum, vol.59, issue.4, pp.264-273, 2016.
DOI : 10.1097/DCR.0000000000000543

P. Rouanet, E. Rullier, B. Lelong, P. Maingon, J. Tuech et al., Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy, Diseases of the Colon & Rectum, vol.60, issue.7, pp.653-663, 2017.
DOI : 10.1097/DCR.0000000000000849

E. Rullier, P. Rouanet, J. Tuech, A. Valverde, B. Lelong et al., Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial, The Lancet, vol.390, issue.10093, pp.31056-31061, 2017.
DOI : 10.1016/S0140-6736(17)31056-5

S. Julião, G. Ortega, C. Vailati, B. Habr-gama, A. Fernandez et al., Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer, Colorectal Dis, vol.6, pp.196-203, 2017.